Integrated Service



Draconis Pharma offers an integrated service covering all development from target validation to candidate selection. Our multidisciplinary teams in collaboration with our customers, will design a drug discovery strategy adapted to the specific needs of each project.

The integrated service covers target validation, assay development, high throughput screening (HTS), hit-to-lead, lead optimization and full efficacy, ADME, toxicity and safety characterization of preclinical candidates.

(for further information or specific requirements, please contact us)

  • Pharmacological target validation

  • Assay development & HTS (Hit-finding campaigns)

  • Synthesis and screening of compounds (Hit-to-lead & lead optimization campaigns)

  • Characterization of a candidate profile (Efficacy, Physicochemical properties, ADME-PK, Toxicity and Safety)

  • Identification and validation of inflammation-related biomarkers
mail enisa